DRW Holdings »

Aeglea Biotherapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $190k 12k 16.57

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Ishares Bitcoin Trust Etf Common Call Option (IBIT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Vaneck Semiconductor Etf Common Put Option (SMH)
Ishares Tr Ishares Common Put Option (SOXX)
Tesla Motors Call Option (TSLA)
Palo Alto Networks Call Option (PANW)
Circle Internet Group Com Cl A Call Option (CRCL)
Micron Technology Common Call Option (MU)
Ishares Ethereum Tr SHS Call Option (ETHA)
NVIDIA Corporation Call Option (NVDA)
Vestas Call Option (VWSYF)
Crowdstrike Hldgs Cl A Call Option (CRWD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)

View all positions for DRW Holdings

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics